These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24794115)

  • 1. Rotor stability separates sustained ventricular fibrillation from self-terminating episodes in humans.
    Krummen DE; Hayase J; Morris DJ; Ho J; Smetak MR; Clopton P; Rappel WJ; Narayan SM
    J Am Coll Cardiol; 2014 Jun; 63(24):2712-21. PubMed ID: 24794115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rotors exhibit greater surface ECG variation during ventricular fibrillation than focal sources due to wavebreak, secondary rotors, and meander.
    Ho G; Villongco CT; Yousefian O; Bradshaw A; Nguyen A; Faiwiszewski Y; Hayase J; Rappel WJ; McCulloch AD; Krummen DE
    J Cardiovasc Electrophysiol; 2017 Oct; 28(10):1158-1166. PubMed ID: 28670858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modifying Ventricular Fibrillation by Targeted Rotor Substrate Ablation: Proof-of-Concept from Experimental Studies to Clinical VF.
    Krummen DE; Hayase J; Vampola SP; Ho G; Schricker AA; Lalani GG; Baykaner T; Coe TM; Clopton P; Rappel WJ; Omens JH; Narayan SM
    J Cardiovasc Electrophysiol; 2015 Oct; 26(10):1117-26. PubMed ID: 26179310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular fibrillation in myopathic human hearts: mechanistic insights from in vivo global endocardial and epicardial mapping.
    Massé S; Downar E; Chauhan V; Sevaptsidis E; Nanthakumar K
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2589-97. PubMed ID: 17259437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lifetimes of epicardial rotors in panoramic optical maps of fibrillating swine ventricles.
    Kay MW; Walcott GP; Gladden JD; Melnick SB; Rogers JM
    Am J Physiol Heart Circ Physiol; 2006 Oct; 291(4):H1935-41. PubMed ID: 16632545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cycle length characteristics differentiating non-sustained from self-terminating ventricular fibrillation in Brugada syndrome.
    Cismaru G; Brembilla-Perrot B; Pauriah M; Zinzius PY; Sellal JM; Schwartz J; Sadoul N
    Europace; 2013 Sep; 15(9):1313-8. PubMed ID: 23419658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatiotemporal Progression of Early Human Ventricular Fibrillation.
    Vidmar D; Krummen DE; Hayase J; Narayan SM; Ho G; Rappel WJ
    JACC Clin Electrophysiol; 2017 Dec; 3(12):1437-1446. PubMed ID: 29238755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A governing equation for rotor and wavelet number in human clinical ventricular fibrillation: Implications for sudden cardiac death.
    Dharmaprani D; Jenkins EV; Quah JX; Lahiri A; Tiver K; Mitchell L; Bradley CP; Hayward M; Paterson DJ; Taggart P; Clayton RH; Nash MP; Ganesan AN
    Heart Rhythm; 2022 Feb; 19(2):295-305. PubMed ID: 34662707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical mapping of Langendorff-perfused human hearts: establishing a model for the study of ventricular fibrillation in humans.
    Nanthakumar K; Jalife J; Massé S; Downar E; Pop M; Asta J; Ross H; Rao V; Mironov S; Sevaptsidis E; Rogers J; Wright G; Dhopeshwarkar R
    Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H875-80. PubMed ID: 17369453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal Impulse and Rotor Modulation for the Treatment of Atrial Fibrillation: Locations and 1 Year Outcomes of Human Rotors Identified Using a 64-Electrode Basket Catheter.
    Tilz RR; Lin T; Rillig A; Heeger CH; Scholz L; Wohlmuth P; Bucur T; Metzner A; Mathew S; Wissner E; Ouyang F; Kuck KH
    J Cardiovasc Electrophysiol; 2017 Apr; 28(4):367-374. PubMed ID: 28039924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observable Atrial and Ventricular Fibrillation Episode Durations Are Conformant With a Power Law Based on System Size and Spatial Synchronization.
    Dharmaprani D; Tiver K; Salari Shahrbabaki S; Jenkins EV; Chapman D; Strong C; Quah JX; Tonchev I; O'Loughlin L; Mitchell L; Tung M; Ahmad W; Stoyanov N; Aguilar M; Niederer SA; Roney CH; Nash MP; Clayton RH; Nattel S; Ganesan AN
    Circ Arrhythm Electrophysiol; 2024 Jul; 17(7):e012684. PubMed ID: 38939983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the activation patterns between sustained and self-terminating episodes of human ventricular fibrillation.
    Mäkikallio TH; Huikuri HV; Myerburg RJ; Seppänen T; Kloosterman M; Interian A; Castellanos A; Mitrani RD
    Ann Med; 2002; 34(2):130-5. PubMed ID: 12108576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracking rotors with minimal electrodes: modulation index-based strategy.
    Balasundaram K; Umapathy K; Jeyaratnam J; Niri A; Massé S; Farid T; Nair K; Asta J; Cusimano RJ; Vigmond E; Nanthakumar K
    Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):447-55. PubMed ID: 25740825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive phase mapping of persistent atrial fibrillation in humans: Comparison with invasive catheter mapping.
    Metzner A; Wissner E; Tsyganov A; Kalinin V; Schlüter M; Lemes C; Mathew S; Maurer T; Heeger CH; Reissmann B; Ouyang F; Revishvili A; Kuck KH
    Ann Noninvasive Electrocardiol; 2018 Jul; 23(4):e12527. PubMed ID: 29271538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epicardial rotors in panoramic optical maps of fibrillating swine ventricles.
    Kay MW; Rogers JM
    Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():2268-71. PubMed ID: 17946949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and electrophysiologic predictors of ventricular tachyarrhythmia recurrence in patients with implantable cardioverter defibrillators.
    Gillis AM; Sheldon RS; Wyse DG; Duff HJ; Cassidy MR; Mitchell LB
    J Cardiovasc Electrophysiol; 2003 May; 14(5):492-8. PubMed ID: 12776866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mode of initiation and ablation of ventricular fibrillation storms in patients with ischemic cardiomyopathy.
    Marrouche NF; Verma A; Wazni O; Schweikert R; Martin DO; Saliba W; Kilicaslan F; Cummings J; Burkhardt JD; Bhargava M; Bash D; Brachmann J; Guenther J; Hao S; Beheiry S; Rossillo A; Raviele A; Themistoclakis S; Natale A
    J Am Coll Cardiol; 2004 May; 43(9):1715-20. PubMed ID: 15120835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolongation of minimal action potential duration in sustained fibrillation decreases complexity by transient destabilization.
    Bingen BO; Askar SF; Schalij MJ; Kazbanov IV; Ypey DL; Panfilov AV; Pijnappels DA
    Cardiovasc Res; 2013 Jan; 97(1):161-70. PubMed ID: 22977009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms underlying ventricular tachycardia and its transition to ventricular fibrillation in the structurally normal heart.
    Samie FH; Jalife J
    Cardiovasc Res; 2001 May; 50(2):242-50. PubMed ID: 11334828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purkinje network and myocardial substrate at the onset of human ventricular fibrillation: implications for catheter ablation.
    Haissaguerre M; Cheniti G; Hocini M; Sacher F; Ramirez FD; Cochet H; Bear L; Tixier R; Duchateau J; Walton R; Surget E; Kamakura T; Marchand H; Derval N; Bordachar P; Ploux S; Takagi T; Pambrun T; Jais P; Labrousse L; Strik M; Ashikaga H; Calkins H; Vigmond E; Nademanee K; Bernus O; Dubois R
    Eur Heart J; 2022 Mar; 43(12):1234-1247. PubMed ID: 35134898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.